Bloom vs. Oklo in 2026: Real Revenue Today or a Bigger Nuclear Bet?

Bloom offers reported revenue today; Oklo offers a later-stage nuclear option

The cleaner split is evidence now versus option value later. Bloom is the stock you buy when you want proof in the income statement today. It just posted its first $1.065 billion quarter and raised full year 2026 revenue guidance to a 100% year-over-year growth midpoint. Oklo is the stock you buy if you think the biggest nuclear payoff sits beyond permitting, construction, and first power. Its Meta-backed Ohio plans still look years from commercial delivery, so the upside depends more on execution over time than on current earnings.

Why the timing matters in 2026

This is not really a choice between two clean-power stories. It is a choice between two different clock cycles. Bloom is already scaling, and its numbers are becoming harder to dismiss as a future dream. Oklo, by contrast, has a near-term catalyst window opening: it reports on August 7, 2026, and that update could sharpen the debate over how quickly financing, regulation, and project development translate into tangible progress.

Bears may argue Oklo's Ohio deal is the real signal because it is tied to a hyperscaler and could reach 1.2 GW. That may prove right over time. But the trade-off is straightforward: Bloom offers evidence in front of the eye; Oklo offers a larger prize further down the road, with execution and permitting timelines as the main risk.

Bloom's advantage is that hardware growth is showing up in revenue and margins

Bloom's edge is that the story is moving from promise to proof. The key signal is not just fast growth. It is that growth is concentrating in the part of the business tied to actual hardware shipments, while profitability improves at the same time.

Product revenue is carrying the expansion

In the second quarter, product revenue of $935.4 million surged 215.4%, outpacing overall revenue growth of 165.5%. That matters because product revenue is a cleaner read-through for shipped power systems and real customer demand. It is easier to trust a business when equipment sales, not just services or timing, are building the top line. And this was not a one-quarter pop: Bloom has now raised full year 2026 guidance in the first quarter and again last week, which suggests demand is holding.

Margin expansion is becoming part of the story

The better evidence of quality is that scale is starting to show up in profitability. Bloom posted gross margin of 33.4%, up from 30.0% in the first quarter and 26.7% a year earlier. Operating income rose to $182.2 million, compared with a $3.5 million operating loss a year ago and $72.2 million in the first quarter. In plain English, Bloom is keeping more of each sales dollar as it scales. That is what investors want to see when a growth stock starts to look like a real operating business rather than a future concept dressed up as revenue.

What could drive the next re-rating

For Bloom, the next move likely comes from confirmation, not promise. The next report matters if it shows another guidance lift or confirms that gross margin and operating income remain strong as shipments keep running at this pace. If product demand and margin expansion stay together, the market has fresh reason to treat Bloom less like a story stock and more like a scaling power supplier.

Oklo still has more upside, but licensing, fuel, and financing still have to line up

Oklo's upside is bigger, but the path to paid power still runs through a three-part test: regulators, fuel, and project financing. If all three move forward together, the market can start to treat Oklo less like a concept and more like a future cash-flowing asset base. If one leg wobbles, the story stays more theoretical for longer.

Meta gives Oklo a demand signal, but it does not replace execution

Start with demand. Oklo's agreement with Meta advances its 1.2 GW nuclear energy development in southern Ohio and provides a mechanism for Meta to prepay for power and help de-risk the project. That matters because nuclear projects do not attract serious capital on vision alone. They need an off-taker, some early cash movement, and evidence that Phase 1 can get built. The bullish case is not just that someone wants the power; it is that a hyperscaler is helping turn demand into development support.

Licensing is the next proof point

The next leg is the license. Oklo says its Ohio project is moving toward the combined license application stage, and the company says it has submitted the first custom combined license application for an advanced fission technology to the NRC. That matters because it suggests Oklo is trying to build a repeatable regulatory process, not just chase headlines.

Fuel remains the most debated input

Fuel is the third leg, and this is where the near-term debate gets real. Oklo was selected by the DOE for advanced negotiations under a program that could support surplus plutonium use as a bridge fuel. That does not guarantee fuel availability, but it does support the idea that Oklo is pursuing multiple pathways rather than relying on a single assumption. For the bull case to hold, financing, licensing, and fuel access all still need to advance together.

What to watch on and after August 7

• Any update on Ohio financing, prepayments, or how far Meta funding carries Phase 1.
• Any sign the NRC is moving from submission to a formal review timeline.
• Any milestone on fuel procurement or DOE bridge-fuel access.
• Whether management shows a repeatable playbook for later projects, not just a heroic first build.

If Oklo can show progress across those fronts, the option value starts to look more like a pipeline. If not, investors are still holding a large future prize with a long leash.

For 2026, Bloom is the cleaner buy for most investors

The better buy in 2026 depends on what kind of risk you want: execution risk on a business that is already scaling, or timing risk on a business that still has to prove the full project chain can execute.

Why Bloom ranks first for this year

If you want a stock where demand is already showing up in reported results, Bloom is the cleaner pick. It just posted its first $1.065 billion quarter and raised full year 2026 revenue guidance, which makes the business easier to model and easier to value today. That is the right choice if you care more about evidence in the financial statements than maximum long-term upside.

Why Oklo remains the higher-risk alternative

If you are chasing the bigger moonshot, Oklo still has the more valuable option. But that option only gets more valuable if the permit-fuel-money machine keeps moving. The company is moving toward the combined license application stage in Ohio, has submitted the first custom combined license application for advanced fission, and was selected for advanced negotiations on surplus plutonium as bridge fuel. The next report on August 7 matters because it may show whether those pieces are starting to connect before market opens on Friday, August 7.

The 2026 ranking

1) Bloom - better buy for most investors this year, because the market can value what it can already see.

2) Oklo - better buy only if you want a larger, later prize. It wins only if these catalysts keep stacking: - Validating sign: financing, licensing, and fuel updates all move together. - Invalidation sign: one leg stalls and the story stays theoretical longer.